You are here: Industry Insights > cancer

News List

Edge Therapeutics & PDS Biotechnology to Merge contractpharma
November 27, 2018
Edge Therapeutics, Inc. and PDS Biotechnology Corporation announced that their respective boards of directors have approved a definitive merger agreement.
Anchiano Therapeutics Names CMO contractpharma
November 27, 2018
David Kerstein, M.D., has been named chief medical officer of Anchiano Therapeutics, a clinical-stage biopharma company focused on novel therapies to treat cancer.
Breast implants reveal problems in tracking device safety foxbusiness
November 27, 2018
To all the world, it looked like breast implants were safe. From 2008 to 2015, the U.S. Food and Drug Administration publicly reported 200 or .....
Most pharma firms doing little R&D for poorer patients pharmaphorum
November 22, 2018
A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects.
Merck and Palantir to form JV to advance cancer research pharmaceutical
November 21, 2018
Merck has signed a non-binding term sheet to establish a joint venture (JV) with data analytics firm Palantir Technologies to support the advancement of cancer research.
Boehringer partners with Epizyme to develop new cancer therapies pharmaceutical-technology
November 19, 2018
Boehringer Ingelheim has formed a global alliance with US-based biopharmaceutical firm Epizyme for the research, development and commercialisation of new potential cancer treatments.
World Menopause Month: moving from HRT to non-hormonal therapies pharmaceutical
November 19, 2018
World Menopause Month, which runs throughout October, raises awareness of menopause and associated disorders and diseases.
After historic win, Lilly partner Chi-Med’s Elunate flops in lung cancer fiercepharma
November 19, 2018
Hutchison China MediTech’s Elunate, which recently became the first China-made drug to win a major oncology approval, has flopped in a key non-small cell lung cancer trial.
Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE-Therapeutics b3cnewswire
November 17, 2018
NBE Therapeutics AG, a biopharmaceutical company developing next-generation immune-stimulatory antibody-drug conjugates (iADCs™) for improved cancer therapy, today announces the appointment of Dr. Anthony Tolcher to NBE's Scientific Advisory Board (SAB).
Obesity both feeds tumors and helps immunotherapy kill cancer worldpharmanews
November 15, 2018
A groundbreaking new study by UC Davis researchers has uncovered why obesity both fuels cancer growth and allows blockbuster new immunotherapies to work better against those same tumors. The paradoxical findings, published today in Nature Medicine, give c

Previous page 1 2 3 4 5 6 7 8 9 10 ... 88 89 Next page